Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT00112346 · COMPLETED

Trial details

NCT number: NCT00112346
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2005-01-01
Primary completion: 2006-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.